Office of the Director; Notice of Charter Renewal, 73565 [2022-26061]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 229 / Wednesday, November 30, 2022 / Notices
our estimate of the average burdens per
response reported in table 2 on our
experience with the existing FALCPA
petition process. We estimate that a
petition would take, on average, 100
hours to develop and submit.
The burden of a notification involves
collecting documentation that a food
ingredient does not pose an allergen
risk. Either we can make a
determination that the ingredient does
not cause an allergic response that poses
a risk to human health under a
premarket approval or notification
program under section 409 of the FD&C
Act (21 U.S.C. 348), or the respondent
would submit scientific evidence
demonstrating that the ingredient when
manufactured as described does not
contain allergenic protein. Based on the
existing FALCPA notification process,
we estimate that the average time to
prepare and submit a notification for
sesame is approximately 68 hours.
Thus, the total annual reporting burden
would be 168 hours over the next 3
years.
III. Electronic Access
Persons with access to the internet
may obtain the guidance documents at
https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments, https://www.fda.gov/
FoodGuidances, or https://
www.regulations.gov. Use the FDA
website listed in the previous sentence
to find the most current version of the
guidances.
Dated: November 23, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–26110 Filed 11–29–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
Office of the Director; Notice of Charter
Renewal
In accordance with title 42 of the U.S.
Code of Federal Regulations, section
217a, notice is hereby given that the
Charter for the National Toxicology
Program Board of Scientific Counselors
was renewed for an additional two-year
period on November 9, 2022.
It is determined that the National
Toxicology Program Board of Scientific
Counselors is in the public interest in
connection with the performance of
duties imposed on the National
Institutes of Health by law, and that
these duties can best be performed
VerDate Sep<11>2014
16:58 Nov 29, 2022
Jkt 259001
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), Telephone (301)
496–2123, or harriscl@mail.nih.gov.
Dated: November 23, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–26061 Filed 11–29–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics in Nephrology.
Date: December 6, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stacey Nicole Williams,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, stacey.williams@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
73565
Dated: November 23, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–26063 Filed 11–29–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, which was
published in the Federal Register on
November 03, 2022, FR Doc 2022–
23900, 87 FR 66315.
This notice is being amended to
change the dates of this two-day
meeting from November 28–29, 2022, to
December 20–21, 2022. The meeting
time remains the same. The meeting is
closed to the public.
Dated: November 23, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–26062 Filed 11–29–22; 8:45 am]
BILLING CODE 4140–01–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–22–051]
Sunshine Act Meetings
Agency Holding the Meeting: United
States International Trade Commission.
TIME AND DATE: December 1, 2022 at 2:00
p.m.
PLACE: Room 101, 500 E Street SW,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none.
2. Minutes.
3. Ratification List.
4. Commission vote on Inv. Nos. 731–
TA–1082–1083 (Third Review)
(Chlorinated Isocyanurates from China
and Spain). The Commission currently
is scheduled to complete and file its
determinations and views of the
Commission on December 19, 2022.
5. Outstanding action jackets: none.
CONTACT PERSON FOR MORE INFORMATION:
William Bishop, Supervisory Hearings
and Information Officer, 202–205–2595.
The Commission is holding the
meeting under the Government in the
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 87, Number 229 (Wednesday, November 30, 2022)]
[Notices]
[Page 73565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26061]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter Renewal
In accordance with title 42 of the U.S. Code of Federal
Regulations, section 217a, notice is hereby given that the Charter for
the National Toxicology Program Board of Scientific Counselors was
renewed for an additional two-year period on November 9, 2022.
It is determined that the National Toxicology Program Board of
Scientific Counselors is in the public interest in connection with the
performance of duties imposed on the National Institutes of Health by
law, and that these duties can best be performed through the advice and
counsel of this group.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail Stop Code 4875), Telephone (301) 496-2123, or
[email protected].
Dated: November 23, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26061 Filed 11-29-22; 8:45 am]
BILLING CODE 4140-01-P
